Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery
NCT05965492 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2025-06-03
Summary
The purpose of this research is to compare two outpatient pain management strategies in patients undergoing spinal surgeries such as microdiscectomies, foraminotomies, and spinal decompressions.
Conditions
- Spinal Disorder
Interventions
- DRUG
-
Day 1 and Day 2: 1000 mg three times a day administered via tablet by mouth for a total cumulative daily dose of 3000 mg. Day 3 and Day 4: 825 mg three times a day administered via tablet by mouth for a total cumulative daily dose of 2475 mg. Day 5: 500 mg two times a day and 325 mg once a day administered via tablet by mouth for a total cumulative daily dose of 1325 mg. Day 6: 500 mg once a day and 325mg twice a day administered via tablet by mouth for a total cumulative daily dose of 1150 mg. Day 7: 500 mg twice a day administered via tablet by mouth for a total cumulative daily dose of 1000 mg.
- DRUG
-
Celebrex
Day 1: 200 mg twice a day administered via tablet by mouth for a total cumulative daily dose of 400 mg. Day 2 and Day 3: 100 mg three times a day administered via tablet by mouth for a total cumulative daily dose of 300 mg. Day 4: 100 mg twice a day administered via tablet by mouth for a total cumulative daily dose of 200 mg. Day 5: 50 mg twice a day administered via tablet by mouth for a total cumulative daily dose of 100 mg. Not prescribed on Days 6 and 7.
- DRUG
-
Gabapentin
Day 1 and Day 2: 300 mg three times a day administered via tablet by mouth for a total cumulative daily dose of 900 mg. Day 3: 200 mg three times a day administered via tablet by mouth for a total cumulative daily dose of 600 mg. Day 4: 200 mg two times a day and 100mg once a day administered via tablet by mouth for a total cumulative daily dose of 500 mg. Day 5: 100 mg three times a day administered via tablet by mouth for a total cumulative daily dose of 300 mg. Day 6: 100 mg two times a day administered via tablet by mouth for a total cumulative daily dose of 200 mg. Day 7: 100 mg once a day administered via tablet by mouth for a total cumulative daily dose of 100 mg.
- DRUG
-
Famotidine
Day 1- Day 7: 20 mg once a day administered via tablet by mouth for a total cumulative daily dose of 20 mg.
- DRUG
-
Decadron
Day 1: 4 mg three times a day administered via tablet by mouth for a total cumulative daily dose of 12 mg. Day 2: 4 mg two times a day administered via tablet by mouth for a total cumulative daily dose of 8 mg. Day 3: 2 mg two times a day administered via tablet by mouth for a total cumulative daily dose of 4 mg. Not prescribed on Days 4 through 7.
- DRUG
-
Oxycodone
A prescription of oxycodone as per standard of care will be provided to participants in case of breakthrough pain.
Sponsors & Collaborators
-
University of Miami
lead OTHER
Principal Investigators
-
Yiliam Yiliam, MD · Professor of Clinical
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2025-06-01
- Completion
- 2025-06-01
- FDA Drug
- Yes
More Related Trials
-
Comparing Analgesia for Postoperative Pain Relief in Spine Surgery
NCT02968862 ·Status: COMPLETED
-
Pain Management After Surgery
NCT05154682 ·Status: UNKNOWN ·Phase: PHASE3
-
An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery
NCT04522206 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Oxycodone Combined With Pregabalin on Chronic Postsurgical Pain in Spinal Surgery
NCT05795478 ·Status: RECRUITING ·Phase: NA
-
Pain Management in Head and Neck Surgery Patients
NCT03121963 ·Status: WITHDRAWN ·Phase: PHASE4
-
Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Treatment in Spinal Surgery
NCT05764707 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate Tissue Expander (TE) Reconstruction
NCT02161705 ·Status: TERMINATED ·Phase: PHASE3
-
Opioid-Free Orthopaedics
NCT04659317 ·Status: RECRUITING ·Phase: PHASE3
-
Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients
NCT03088306 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prospective, Randomized, Double Blind Study Comparing IV vs PO Acetaminophen in Patients Undergoing Lumbar Discectomy
NCT02067442 ·Status: UNKNOWN ·Phase: NA
-
Multimodal Perioperative Pain Management
NCT01513564 ·Status: COMPLETED ·Phase: NA
-
Multimodal Pain Study in Free Flap Patients
NCT04246697 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
NCT05494502 ·Status: RECRUITING ·Phase: NA
-
The Use of Intrathecal Morphine in the Management of Acute Pain Following Decompressive Lumbar Spinal Surgery
NCT01053039 ·Status: COMPLETED ·Phase: PHASE4
-
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
NCT04176419 ·Status: TERMINATED ·Phase: PHASE3
-
Intravenous Methocarbamol for Acute Pain After Spine Surgery
NCT06659965 ·Status: COMPLETED
-
A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
NCT06545097 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty
NCT04242407 ·Status: UNKNOWN ·Phase: PHASE2
-
Oral Versus Intravenous Acetaminophen in Lumbar Spine Surgery
NCT07203079 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Shifting Pain Modulation From Pro-to Anti-nociceptive
NCT02672202 ·Status: TERMINATED ·Phase: NA
-
Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery
NCT04990804 ·Status: TERMINATED ·Phase: PHASE4
-
OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
NCT05452694 ·Status: RECRUITING
-
Does Intrathecal Morphine Affect Outcomes in Spine Deformity Surgery
NCT05092828 ·Status: UNKNOWN ·Phase: PHASE4
-
Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes
NCT05718544 ·Status: COMPLETED ·Phase: PHASE4
-
Analgesic Protocol With Gabapentin Dexmedetomidine For Postoperative Pain Managment
NCT04976374 ·Status: UNKNOWN ·Phase: NA